THE EFFECT OF COMBINATION THERAPY WITH PEGINTERFERON ALFA-2B PLUS ENTECAVIR DURING 48 WEEKS FOR CHRONIC HEPATITIS B

被引：0
|
作者：
Inuzuka, Tadashi [1 ]
Takeda, Haruhiko [1 ]
Kanesaka, Takashi [1 ]
Kanesaka, Takashi [1 ]
Nakajima, Jun [1 ]
Matsuda, Fumihiro [1 ]
Sakamoto, Azusa [1 ]
Hatamaru, Keiichi [1 ]
Henmi, Shinichiro [1 ]
Ishikawa, Tetsuro [1 ]
Saito, Sumio [1 ]
Saito, Sumio [1 ]
Nishikawa, Hiroki [1 ]
Nishikawa, Hiroki [1 ]
Kita, Ryuichi [1 ]
Kimura, Toru [1 ]
Osaki, Yukio [1 ]
机构：
[1] Osaka Red Cross Hosp, Osaka, Japan
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1063A / 1063A
页数：1
相关论文
共 50 条
  • [1] Peginterferon alfa-2b plus ribavirin for chronic hepatitis
    Cecil, BD
    LANCET, 2002, 359 (9302): : 263 - 264
  • [2] Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C
    Yeh, Frank
    Gordon, Fredric D.
    FUTURE VIROLOGY, 2007, 2 (06) : 553 - 563
  • [3] NARLAPREVIR AND PEGINTERFERON ALFA-2B FOR 2 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS, FOLLOWED BY PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR 24/48 WEEKS: FINAL RESULTS
    de Bruijne, J.
    Bergmann, J. F.
    Weegink, C. J.
    Molenkamp, R.
    Schinkel, J.
    Treitel, M. A.
    Hughes, E. A.
    van Vliet, A.
    de Knegt, R. J.
    Reesink, H. W.
    Janssen, H. L. A.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S290 - S291
  • [4] Peginterferon alfa-2b plus ribavirin for chronic hepatitis - Reply
    Manns, MP
    McHutchison, J
    Koury, K
    Albrecht, JK
    LANCET, 2002, 359 (9302): : 264 - 264
  • [5] Peginterferon alfa-2b plus ribavirin for retreatment of chronic hepatitis C
    Dalke, DD
    Donovan, J
    Mailliard, M
    Monsour, H
    GASTROENTEROLOGY, 2004, 126 (04) : A667 - A667
  • [6] Effect of combination therapy peginterferon alfa-2b and ribavirin on prevention of hepatocellular carcinoma in advanced chronic hepatitis C
    Honda, Takashi
    Katano, Yoshiaki
    Kuzuya, Teiji
    Hayashi, Kazuhiko
    Ishigami, Masatoshi
    Nakano, Isao
    Toyoda, Hidenori
    Kumada, Takashi
    Yoshioka, Kentaro
    Goto, Hidemi
    HEPATOLOGY, 2012, 56 : 1002A - 1003A
  • [7] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    Manns, MP
    McHutchison, JG
    Gordon, SC
    Rustgi, VK
    Shiffman, M
    Reindollar, R
    Goodman, ZD
    Koury, K
    Ling, MH
    Albrecht, JK
    LANCET, 2001, 358 (9286): : 958 - 965
  • [8] Peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
    Crespo, M
    Sauleda, S
    Esteban, JI
    Juarez, A
    Buti, M
    Pahissa, A
    Esteban, R
    Guardia, J
    HEPATOLOGY, 2005, 42 (04) : 701A - 702A
  • [9] Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
    Brixner, Diana I.
    Ye, Xin
    Chu, Teng-Chiao
    Blumentals, William A.
    Hassanein, Tarek I.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (24) : 2171 - 2178
  • [10] Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Al-Ajmi, M
    Owaid, S
    Varghese, R
    Al-Nakib, B
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1733 - 1737
12345